Back to the search results

Cellitinnen-Krankenhaus Heilig Geist

Cellitinnen-Krankenhaus Heilig Geist
Cellitinnen-Krankenhaus Heilig Geist

Graseggerstraße 105
50737 Köln

Phone: 0221-7491-0
Mail: ed.nennitillec@tsieggilieh-hk.ofni info.kh-heiliggeist@cellitinne... ed.nennitillec@tsieggilieh-hk.ofni

http://www.hgk-koeln.de/
  • Number of beds: 291
  • Number of specialist departments: 7
  • Number of inpatient cases: 16.067
  • Number of outpatient cases: 37.289
  • Hospital owners: Cellitinnen-Krankenhaus Heilig Geist
  • Type of provider: freigemeinnützig
  • Academic teaching hospital
      • Universität zu Köln
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of the minimum quantity agreement
    No participation
No. Explanation
CQ31 Guideline for the care of proximal femur fractures (QSFFx-RL)
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
52 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
45 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
45 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • individuelle Unterstützung von Teams, regelmäßige Treffen der benannten Vertrauenspersonen; Supervision
Gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Umgang mit Arzneimitteln

21.07.2020

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal: Zytostatika
  • Bestellung über CGM-Muse
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Training in other healing professions
Comment

LvM + KaTHo Köln

Comment

In Kooperation mit der Cellitinnen Akademie Louise von Marillac . Ausbildung zur generalistischen Pflegefachkraft in Kooperation mit verschiedenen anderen Einrichtungen (Caritas, Rhein-Erft Kreis, Kinderklinik Amsterdamer Str. etc.)

Comment

Ausbildung zur Pflegefachassistenz (1-jährige Ausbildung) an der Cellitinnen Akademie Louise von Marillac Schule

Comment

In Kooperation mit der Medical School und der AFG-Wuppertal.

Comment

In Kooperation mit der Medical School.

Comment

In Kooperation mit dem Universitätsklinikum Köln: Studium BSc. Hebammenwesen

Annemarie Herberg

Patientenfürsprecherin

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-1303
Mail: ed.nennitillec@tsieggilieh-hk.nirehcerpsreufnetneitaP

Carolin Emersleben

Qualitätsmanagement

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-8445
Mail: ed.nennitillec@nebelsreme.nilorac

Christine Winter

Qualitäts- und Risikomanagement

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-1336
Mail: ed.nennitillec@retniw.enitsirhC

Laura Draber

Qualitätsmanagement

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-1309
Mail: ed.nennitillec@rebard.arual

Christine Winter

Qualitätsmanagement

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-1336
Mail: ed.nennitillec@retniw.enitsirhc

Prof. Dr. med. Lothar Burghaus

Ärztlicher Direktor und Chefarzt Klinik für Neurologie

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-8421
Mail: ed.nennitillec@suahgrub.rahtol

Monika Linn

Stoma- und Wundmanagement / Schwerbehindertenvertretung

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-1618
Mail: ed.nennitillec@nnil.akinom

Graseggerstraße 105
50737 Köln

Phone: 0221-7491-0
Mail: ed.nennitillec@tsieggilieh-hk.ofni

Dipl. PM FH Susanne Krey

Pflegedirektorin

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-0
Mail: ed.nennitillec@yerk.ennasus

Alexandra Krause

Kaufmännische Direktorin

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-8204
Mail: ed.nennitillec@esuark.ardnaxela

Dipl.-Betriebswirt (BA) Patrick von der Horst

Geschäftsführer

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-8204
Mail: ed.nennitillec@tsrohrednov.kcirtap

Dr. med. Claudius Fridrich

Ärztlicher Direktor und Chefarzt der Klinik für Gynäkologie und Geburtshilfe

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-8288
Mail: ed.nennitillec@hcirdirf.suidualc

Prof. Dr. med. Lothar Burghaus

Ärztlicher Direktor und Chefarzt der Klinik für Neurologie

Graseggerstraße 105
50737 Köln

Phone: 0221 -7491-8421
Mail: ed.nennitillec@suahgrub.rahtol

IK: 260530396

Location number: 772936000

Babyfreundliche Geburtsklinik

Certified until: 06.2027

Dysplasie-Einheit

Certified until: 09.2027

Prostatakrebszentrum

Certified until: 03.2028

Hospital portrait for download